EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes

Masaud Shah, Sung Ung Moon, Ji-Yon Shin, Ji-Hye Choi, Doyoon Kim, Hyun Goo Woo iD

Advanced Science · 2025-04 · 12 (16)

DOI: 10.1002/advs.202409919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.02.2025. Verfasst von Masaud Shah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19 Vaccines, SARS-CoV-2, Epitopes, T-Lymphocyte, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea funded by the Ministry of Science and ICT (MSIT), Korea Health Industry Development Institute, Korea Initiative for fostering University of Research and Innovation Program of the NRF funded by MSIT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of a globally effective COVID‐19 vaccine faces significant challenges, particularly in redirecting the B‐cell response from immunodominant yet variable regions of viral proteins toward their conserved domains. To address this, an integrated strategy is implemented that combines classical B‐cell epitope prediction with protein‐antibody cluster docking and antibody titer analysis from 30 vaccinated and convalescent individuals. This approach yields stable immunodominant and immunoprevalent B‐cell epitopes capable of eliciting robust antibody responses in BALB/c mice and effectively neutralizing pseudoviruses expressing the Spike protein of SARS‐CoV‐2 variants of concern, including Alpha, Beta, Gamma, Delta, and Omicron. To achieve a broader T‐cell‐based immune response, promiscuous T‐cell epitopes are identified by integrating classical T‐cell epitope predictions, differential scanning fluorimetry, and peptide‐MHC structural analysis. Unique peptides with conserved MHC‐anchoring residues are identified, enabling binding to a spectrum of MHC‐I and MHC‐II haplotypes. These peptides elicit strong interferon gamma responses in human peripheral blood mononuclear cells and demonstrate cross‐species efficacy by activating both CD4+ and CD8+ T‐cells in BALB/c mice. Collectively, these findings highlight the significance of innovative vaccine strategies targeting immunodominant/immunoprevalent B‐cell and promiscuous T‐cell epitopes to drive broad and robust humoral and cellular immune responses against a wide range of SARS‐CoV‐2 variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesSARS-CoV-2Epitopes, T-LymphocyteCOVID-19Epitopes, B-LymphocyteAnimalsMiceHumansMice, Inbred BALB CAntibodies, ViralSpike Glycoprotein, CoronavirusFemaleAntibodies, Neutralizing

Stichwörter der Autor:innen

MHCSARS‐CoV‐2multiepitope vaccineneutralizationpan‐variantpeptidesvaccine

Substanzen

COVID-19 VaccinesEpitopes, T-LymphocyteEpitopes, B-LymphocyteAntibodies, ViralSpike Glycoprotein, CoronavirusAntibodies, Neutralizingspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Physiology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea.
  • Ajou Translational Omics Center (ATOC), Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon, 16499, Republic of Korea.
  • AI-Superconvergence KIURI Translational Research Center, Ajou University School of Medicine, Suwon, 16499, Republic of Korea.
  • Department of Biomedical Science, Graduate School, Ajou University, Suwon, 16499, Republic of Korea.

ORCID-Profile: Hyun Goo Woo

Förderung

  • National Research Foundation of Korea funded by the Ministry of Science and ICT (MSIT)
  • Korea Health Industry Development Institute
  • Korea Initiative for fostering University of Research and Innovation Program of the NRF funded by MSIT

Zitieren

APA

Shah, M., Moon, S. U., Shin, J. Y., Choi, J. H., Kim, D., & Woo, H. G. (2025). Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes. Advanced Science, 12(16). https://doi.org/10.1002/advs.202409919

Vancouver

Shah M, Moon SU, Shin JY, Choi JH, Kim D, Woo HG. Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes. Advanced Science. 2025;12(16). doi:10.1002/advs.202409919

BibTeX
@article{Shah2025,
  author = {Shah, Masaud and Moon, Sung Ung and Shin, Ji-Yon and Choi, Ji-Hye and Kim, Doyoon and Woo, Hyun Goo},
  title = {Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {16},
  doi = {10.1002/advs.202409919}
}
Kostenlos starten →